Latest

Valuation tracker

Health and bio: private company valuations

OpenEvidence is the most valuable of 2 ranked health and bio companies, at $15B (latest priced valuation). Isomorphic Labs ($50B) has only a figure from reported talks, so it is listed after the ranking. AI drug discovery, clinical AI tools for doctors and brain-computer interfaces.

Updated .

Health and bio companies ranked by valuation
#CompanyValuationRun-rate revenueMultipleIPO statusValuation date
1OpenEvidenceHealth and bio$15BSource tier: Reportedprimary roundPrivate21 Oct 2026

Not ranked: valuations from reported talks

These figures come from reported funding talks or a target, not a priced round, tender or sale, so they sit outside the ranking.

Health and bio companies valued only in reported talks (not ranked)
CompanyValuationRun-rate revenueMultipleIPO statusValuation date
Isomorphic LabsHealth and bio$50BSource tier: Reportedreported talksPrivate17 Nov 2026

Information only, not investment advice. Figures are from public sources; tiers show how solid each one is.

Sources

  1. The Next Web (citing Bloomberg). thenextweb.com, Source tier: Reported
  2. Ars Technica. arstechnica.com, Source tier: Reported
  3. Reuters. reuters.com, Source tier: Reported

Related: full tracker, technical valuation, Anthropic IPO. AI models AI infrastructure Fintech Space and defense

Alerts

Anthropic IPO alerts by e-mail

Get an e-mail when Anthropic starts trading.